Advair.com | Site map | Glossary | Important information about ADVAIR DISKUS® 250/50   
 
COPD
 Home
 What Is COPD?
 How to Manage COPD
 How ADVAIR Helps
 Living With
 Family Members
NEW INFORMATION about ADVAIR for COPD
Has breathing become more difficult?
Chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, is a condition that causes a reduction of airflow in and out of the lungs, which makes breathing more difficult. But today there's a treatment that may help you breathe better.* It's called ADVAIR DISKUS 250/50.

*ADVAIR® 250/50 is clinically proven to help your lungs work better (measured by a breathing test), compared with people taking either fluticasone propionate 250 mcg or salmeterol 50 mcg (inhalation powders). Your results may vary.


Important information about ADVAIR DISKUS 250/50
ADVAIR DISKUS 250/50 is approved for adults with COPD, including chronic bronchitis, emphysema, or both. You should only take 1 inhalation of ADVAIR twice a day. Higher doses will not provide additional benefits. People with COPD taking ADVAIR may have a higher chance of pneumonia. Call your doctor if you notice any of the following symptoms: change in amount or color of sputum, fever, chills, increased cough, or increased breathing problems. ADVAIR may increase your risk of osteoporosis and some eye problems (cataracts or glaucoma). You should have regular eye exams. Thrush in the mouth and throat may occur. Tell your doctor if you have a heart condition or high blood pressure before taking ADVAIR. Do not use ADVAIR with long-acting beta2-agonists for any reason. ADVAIR does not replace fast-acting inhalers for sudden symptoms.

Complete Prescribing Information and Medication Guide for ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder).

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.



GSK Corporation    GSK For You    Contact Us

This site is intended for US residents only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us